Author

R. A. Fanne

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Efficacy of Semaglutide in glycemic control, weight loss, and improving lipid profile- the role of baseline vitamin D levels.

Semaglutide, a glucagon-like peptide-1 receptor agonist, is an established therapy for type 2 diabetes (T2D), offering robust glycemic control and weight reduction. Vitamin D has been implicated in metabolic regulation, yet its influence on semaglutide-induced outcomes remains unclear. Research Design and Method...

R. A. Fanne, A. Israeli · European Heart Journal · 0 citations

Open access Oct 2026

Metabolic health modifies SYNTAX II–Based revascularization risk beyond body mass index

Body mass index (BMI) is widely used for cardiovascular risk stratification, yet it fails to capture underlying cardiometabolic heterogeneity. Whether metabolic–obesity phenotypes are associated with differences in coronary disease complexity and revascularization risk remains incompletely defined. To eval...

R. A. Fanne, T. Kabaha · European Heart Journal · 0 citations

Open access Oct 2026

Coronary revascularization guidance by myocardial perfusion imaging- retrospective real-life data from single center study

Myocardial perfusion imaging (MPI) is widely used for risk stratification and guidance of coronary revascularization in patients with suspected or known coronary artery disease. However, real-world concordance between MPI findings and invasive coronary intervention remains incompletely defined. To evaluate...

R. A. Fanne, M. Hassadie · European Heart Journal · 0 citations